TRIAMCINOLONE ACETONIDE INJECTABLE SUSPE

The Defense Logistics Agency awarded DMS PHARMACEUTICAL GROUP INC a delivery order under contract SPE2DX25D9900 for the procurement of TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION, identified by NSN 6505011467792, with a total contract value of $13.52 for two vials at $6.76 per unit. The award was issued on July 14, 2026, under solicitation SPE2DP26F7674, and the delivery is FOB destination to Fort Bragg, North Carolina, with the contractor responsible for all transportation costs and risk until receipt. The product must be shipped by the fastest traceable means, excluding parcel post, and labeled with the specified Mark For address, TCN W91KBP61950058, NSN, manufacturer CAGE codes 4T649 and 3V8D7, and NDC numbers NDC00003-0293-05 and NDC00703-0241-01. No explicit packaging standards, preservation methods, or barcoding specifications are detailed, though compliance with standard DoD logistics practices is implied. The contract contains no option quantities, delivery flexibility, or variation tolerance, with a strict QTY VARIANCE of plus or minus zero percent. No FAR clauses, Section H special requirements, evaluation criteria, or representations and certifications are included in the documentation, and no contracting officer, COR, or COTR information is provided. The procurement is treated as a direct acquisition of a single off-the-shelf pharmaceutical item under federal supply channels, with acceptance occurring at the delivery point and no formal Statement of Work or inspection criteria beyond confirmation of product identity and quantity.